Check whether Urolithin A can be measured from blood spots
This study tests whether a substance called urolithin A can be detected using dried blood spots (small samples on a card). It also checks whether people can safely take the study product and complete questionnaires during the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You are in generally good health, based on the study team’s check
- You agree to take the study product and follow study steps (including questionnaires)
- You can give informed consent electronically and understand what you’re agreeing to
- You do not have a known allergy or sensitivity to the study product ingredients
- You have not taken antibiotics in the past 30 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a daily supplement called Urolithin A (Mitopure®) can improve muscle strength in healthy middle-aged adults who are not very active. Researchers will measure changes in strength and fitness over several weeks.
This study checks how a natural compound called urolithin A moves into the fluid around the brain and spine after you take it. It may help researchers understand if it can be used for brain health.
This study looks at the amount of tiny plastic particles (microplastics) in urine from people with kidney or ureter stones. The goal is to see if these particles are linked to stone formation, which could help prevent stones in the future.
This study looks for “biomarkers,” which are measurable signs in samples like urine or blood, to help understand and detect recurring urinary stone disease. It may help future patients by improving how doctors predict stone recurrence or identify stone types.
This study tests a product designed to support urinary health. The goal is to see if it helps reduce frequent urination and urgency in healthy Japanese adults who have mild bladder symptoms.
This study collects urine samples to test UroAmp, a new genetic test that may help detect and monitor bladder cancer. It is for people with bladder cancer or blood in urine who want to help improve cancer detection.
Hear when a new Healthy Aging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.